{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T13:24:02Z","timestamp":1773753842249,"version":"3.50.1"},"reference-count":0,"publisher":"Georg Thieme Verlag KG","issue":"S 01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch med Wochenschr"],"DOI":"10.1055\/s-0032-1305284","type":"journal-article","created":{"date-parts":[[2013,3,25]],"date-time":"2013-03-25T19:36:46Z","timestamp":1364240206000},"page":"S27-S39","source":"Crossref","is-referenced-by-count":3,"special_numbering":"suppl","title":["Langzeitwirkung von Dapagliflozin bei Typ-2-Diabetikern unter hoch dosierter Insulintherapie"],"prefix":"10.1055","volume":"138","author":[{"given":"J.","family":"Wilding","sequence":"additional","affiliation":[{"name":"Forschungsgruppe Diabetes und Endokrinologie, Abteilung Adipositas und Endokrinologie, Zentrum f\u00fcr klinische Wissenschaft, Universit\u00e4tsklinik Aintree, Liverpool, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Woo","sequence":"additional","affiliation":[{"name":"Universit\u00e4t Manitoba, Abteilung Innere Medizin, Winnipeg, Kanada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Soler","sequence":"additional","affiliation":[{"name":"Springfield Zentrum f\u00fcr Diabetes und Endokrinologie, Springfield, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pahor","sequence":"additional","affiliation":[{"name":"AstraZeneca, Wedel, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sugg","sequence":"additional","affiliation":[{"name":"AstraZeneca, Wilmington, Delaware, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Rohwedder","sequence":"additional","affiliation":[{"name":"AstraZeneca, Wedel, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Parikh","sequence":"additional","affiliation":[{"name":"AstraZeneca, Wilmington, Delaware, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"f\u00fcr die Studiengruppe Dapagliflozin 006","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2013,3,25]]},"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0032-1305284.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T19:25:23Z","timestamp":1495481123000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0032-1305284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,25]]},"references-count":0,"journal-issue":{"issue":"S 01","published-online":{"date-parts":[[2013,3,25]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0032-1305284","relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,25]]}}}